ZAZZI MAURIZIO

Maurizio
Zazzi
Professore Ordinario

Office hours

  • Monday from 16:00 to 18:00
    Place: Studio del docente - Policlinico "Le Scotte"
    Note: Solo previo appuntamento a mezzo e-mail.

Contacts

0577232812 [int.2812]

Curriculum Vitae

Teaching activities

Completion accademic year: 2025/2026

Course year: 2 Second cycle degree (Laurea Magistrale) MEDICAL BIOTECHNOLOGIES A.Y. 2024/2025
Course year: 1 Full cicle (5 years) PHARMACY A.Y. 2025/2026

Completion accademic year: 2024/2025

Course year: 1 Full cicle (5 years) PHARMACY A.Y. 2024/2025

Completion accademic year: 2023/2024

Course year: 1 Second cycle degree (Laurea Magistrale) MEDICAL BIOTECHNOLOGIES A.Y. 2023/2024
Course year: 1 Full cicle (5 years) PHARMACY A.Y. 2023/2024

Completion accademic year: 2022/2023

Course year: 1 Second cycle degree (Laurea Magistrale) MEDICAL BIOTECHNOLOGIES A.Y. 2022/2023

Research

Ultime pubblicazioni:

  • Rossi, S., Deidda, G., Fiaschi, L., Ibba, R., Pieroni, M., Dichiara, M., et al. (2025). Synthesis and biological investigation of peptidomimetic SARS‐CoV‐2 main protease inhibitors bearing quinoline‐based heterocycles at P3. ARCHIV DER PHARMAZIE, 358(1) [10.1002/ardp.202400812]. - view more
  • Giammarino, F., Paletti, C., Bartolini, N., Fiaschi, L., Biba, C., Varasi, I., et al. (2025). Combined doravirine and islatravir cooperate to inhibit NRTI and NNRTI resistant HIV-1 in vitro. ANTIVIRAL RESEARCH, 239 [10.1016/j.antiviral.2025.106157]. - view more
  • Fiaschi, L., Biba, C., Varasi, I., Bartolini, N., Paletti, C., Giammarino, F., et al. (2024). In Vitro Combinatorial Activity of Direct Acting Antivirals and Monoclonal Antibodies against the Ancestral B.1 and BQ.1.1 SARS-CoV-2 Viral Variants. VIRUSES, 16(2), 1-12 [10.3390/v16020168]. - view more
  • Ripamonti, D., Borghetti, A., Zazzi, M. (2024). Appropriateness of virological monitoring with long-acting injectable cabotegravir and rilpivirine. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 79(10), 2720-2724 [10.1093/jac/dkae257]. - view more
  • Ripamonti, D., Rusconi, S., Zazzi, M. (2024). A cautionary note on entry and exit strategies with long-acting cabotegravir and rilpivirine. AIDS, 38(2), 263-265 [10.1097/QAD.0000000000003760]. - view more